Advertisement

BMC Microbiology

, 19:11 | Cite as

Novel virulence, antibiotic resistance and toxin gene-specific PCR-based assays for rapid pathogenicity assessment of Arcobacter faecis and Arcobacter lanthieri

  • Matthew Zambri
  • Michel Cloutier
  • Zaky Adam
  • David R. Lapen
  • Graham Wilkes
  • Mark Sunohara
  • Edward Topp
  • Guylaine Talbot
  • Izhar U. H. KhanEmail author
Open Access
Research article
Part of the following topical collections:
  1. Applied microbiology

Abstract

Background

Arcobacter faecis and A. lanthieri are two newly classified species of genus Arcobacter. The prevalence and distribution of virulence, antibiotic resistance and toxin (VAT) genes in these species are required to assess their potential pathogenic health impacts to humans and animals. This study (i) developed species- and gene-specific primer pairs for the detection of six virulence, two antibiotic resistance, and three toxin genes in two target species; (ii) optimized eight single-tube multiplex and three monoplex PCR protocols using the newly developed species- and gene-specific primers; and (iii) conducted specificity and sensitivity evaluations as well as validation of eleven mono- and multiplex PCR assays by testing A. faecis (n= 29) and A. lanthieri (n= 10) strains isolated from various fecal and agricultural water sources to determine the prevalence and distribution of VAT genes and assess the degree of pathogenicity within the two species.

Results

Detection of all ten and eleven target VAT genes, and expression of cytolethal distending toxin (cdtA, cdtB and cdtC) genes in A. faecis and A. lanthieri reference strains with high frequency in field isolates suggest that they are potentially pathogenic strains. These findings indicate that these two species can pose a health risk to humans and animals.

Conclusions

The study results show that the developed mono- and multiplex PCR (mPCR) assays are simple, rapid, reliable and sensitive for the simultaneous assessment of the potential pathogenicity and antibiotic resistance profiling of tet(O) and tet(W) genes in these two newly discovered species. Also, these assays can be useful in diagnostic and analytical laboratories to determine the pathotypes and assessment of the virulence and toxin factors associated to human and animal infections.

Keywords

Mono- and multiplex PCR Arcobacter faecis A. lanthieri Pathogenicity Virulence Antibiotic resistance Toxins 

Abbreviations

ASIA

Arcobacter Selective Isolation Agar

BSA

Bovine Serum Albumin

cdt

Cytolethal distending toxin

mPCR

Multiplex PCR

tet

Tetracycline resistance

VAGs

Virulence-associated genes

VAT

Virulence, antibiotic resistance and toxin

Highlights

  1. 1.

    Species- and gene-specific mPCR assays were  developed, optimized and validated for A. faecis and A. lanthieri

     
  2. 2.

    Virulence, antibiotic resistance and toxin genes were rapidly detected in field isolates

     
  3. 3.

    Evaluation of Pathogenicity of A. faecis and A. lanthieri strains

     

Introduction

The genus Arcobacter was proposed in 1991 by Vandamme et al. [1], separating it from genus Campylobacter. It was further amended and enlarged to include a total of over 27 species, with the reclassification of other Arcobacter spp. isolated from various human, animal and environmental sources [2, 3, 4]. The Arcobacter spp., particularly A. butzleri, A. cryaerophilus, A. skirrowii, and A. cibarius, are of interest to research groups because of their prevalence in bovine, porcine, poultry and shellfish [5, 6]. These species have been considered as emerging food- and waterborne zoonotic pathogens [7]. Arcobacter spp. have been associated with various illnesses such as gastroenteritis, bacteremia, and sepsis in humans, mastitis, diarrhea, abortion, and other reproductive disorders in animals [8]. Infection caused by the genus Arcobacter spp. is still considered as a low public health risk because of misidentification by inappropriate detection and typing methods of both Campylobacter and Arcobacter spp., which result in underestimation of the true incidence of Arcobacter infection [9]. Moreover, there is a limited knowledge of key mechanisms (e.g., adhesion, invasion, and cytotoxicity capacity) and potential virulence and toxin factors of Arcobacter spp. [6, 10, 11]. The pathogenesis of bacterial infection depends on enterotoxins, adherence and colonization factors as well as invasiveness and penetrability characteristics where pathogens causing gastrointestinal infection either attach to the surface of epithelial cells or invade the intestinal epithelial cells and replicate in the intestinal lumen and produce a systemic disease [12].

Among several Arcobacter spp., A. faecis and A. lanthieri are two recently discovered species within the genus Arcobacter which were recovered from human waste septic tank and livestock manure, respectively [4, 13]. The two species were distinguished with other Arcobacter spp. through polyphasic approaches that examined several genotypic and phenotypic aspects of A. faecis (LMG 28516T) and A. lanthieri (LMG 28519T) reference strains [4, 13]. Through the genetic analysis performed on the multiple housekeeping gene sequences, it was reported that the two novel species were most closely related to each other as well as to the A. cibarius, A. butzleri, A. cryaerophilus and A. skirrowii. Since these two Arcobacter spp. have been isolated from human and animal fecal sources, it is important to investigate the degree of pathogenicity of these species that can aid in identifying their potential relevance to human and animal infections.

Studies have previously evaluated the occurrence and potential role of virulence-associated genes (VAGs) in the pathogenesis of human and animal infections by the Arcobacter spp. [10, 14]. Other studies have indicated that several VAGs are prevalent in the genus Arcobacter [14, 15, 16] which suggests that several of the Arcobacter spp. potentially possess the ability to pose a significant risk to human health. Among six virulence genes, cadF gene encodes for an integral membrane protein that serves as an adhesion factor which allows the bacteria to bind to the fibronectin proteins found in the extracellular matrix of the host’s intestinal epithelial cells, and is also responsible for activating GTPases of bacterial cells, thus inducing their internalization [17]. The ciaB gene encodes for the Campylobacter invasion antigen B [18], whereas irgA gene encodes for an iron-regulated outer membrane protein. However, mviN gene encodes for an essential protein that is involved in peptidoglycan and cellular membrane synthesis and pldA gene encodes the outer membrane phospholipase A. In addition, tylA encodes for the exotoxin hemolysin A [19].

On the other hand, cytolethal distending toxin (cdt) found in Gram-negative bacteria that has been shown to stall growth of eukaryotic cells in either the G0/G1 or G2/M phases of the cell cycle which inevitably results in cell death. The cdt toxin functions as a heterotrimer of proteins encoded by three separate genes (cdtA, cdtB, and cdtC) that have been recognized for the expression of cytotoxin production [20, 21]. Previous studies have reported the distinct absence of cdt genes from Arcobacter spp. isolated from various sources as well as a genome sequence of A. butzleri strain [19, 22]. Interestingly, it has been determined that the A. faecis reference strain contained only sequences for the cdtA and cdtC genes, compared to the A. lanthieri that revealed sequences for cdtA, cdtB and cdtC genes, respectively [23, 24].

In addition to the pathogenicity aspect, antimicrobial resistance is a serious and increasing threat to human health since their use for growth promotion or treatment of livestock, poultry and aquaculture has a direct impact on this problem. Among several antimicrobial agents, tetracyclines are still considered a clinically relevant antibiotic with limited use due to dissemination of tolerance and resistance determinants [25]. However, tetracyclines are frequently used in livestock, poultry and aquaculture as therapeutic, prophylactic or growth promotors worldwide with significantly high usage in countries such as China and India compared to United States and Europe due to the ban of tetracycline and other antibiotics as growth promoters which enhances the emergence of antibiotic resistant strains, allergic reactions in humans and animals, and changes in environmental microflora and bacterial populations among other detrimental effects [26, 27, 28, 29, 30]. Studies have reported high resistance of A. cryaerophilus to tetracycline [31] compared to A. butzleri that has shown high susceptibility to tetracycline and strong and widespread resistance to several other antibiotics [32, 33, 34]. Tetracycline acts to prevent the synthesis of bacterial proteins by binding to the prokaryotic 30S ribosomal subunit, thus inhibiting initiation of translation [35, 36]. This resistance is due to different tetracycline resistance (tet) genes [37]. Of more than 40 genes encoding tetracycline resistance (tet-genes) that have been characterized, tet(O) and tet(W) genes confer ribosomal protection from the inhibiting effect of tetracycline [36, 38]. Therefore, tet(O) and tet(W) genes were specifically selected for this study as they appear to be promiscuous in environmental organisms through different transfer mechanisms [39, 40], which makes them suitable candidates for understanding the degree of prevalence, distribution and further monitoring of other antibiotic resistance genes in these two species. In order to understand and identify whether these isolates are potentially pathogenic, several virulence, antibiotic and toxin (VAT) genes were identified in both A. faecis and A. lanthieri reference strains [23, 24] by whole-genome sequence analysis.

The present study was undertaken to determine the prevalence of these genes within the fecal matter and agricultural environment based on development and optimization of a total of eleven (three monoplex and eight multiplex) PCR assays using six virulence (cadF, ciaB, irgA, mviN, pldA and tylA), three cytolethal distending toxin (cdtA, cdtB and cdtC) and two tetracycline [tet(O) and tet(W)] genes. The assays were further validated to evaluate the degree of pathogenicity using reference strains and culture isolates recovered from various fecal sources and agricultural surface water samples.

Materials and methods

Reference strains and Arcobacter field culture isolation

For this study, a total of 17 different Arcobacter spp. along with 25 other bacterial reference species and strains isolated from various sources were used to test the newly developed assays (Table 1). The reference strains were grown on selective culture media under specific culture conditions.
Table 1

List of reference strains of Arcobacter and other bacterial species used in this study

Sr. #

Species

Source

Strain ID

1

Arcobacter bivalviorum

Shellfish

LMG 26154

2

A. butzleri

Human diarrheic stool

ATCC 49616

3

A. cibarius

Broiler carcasses

LMG 21996

4

A. cryaerophilus

Bovine aborted fetus

NCTC 11885

5

A. defluvii

Sewage

LMG25694

6

A. ellisii

Mussels

LMG 26115

7

A. faecis

Human septic tank

LMG 28519

8

A. halophilus

Hypersaline lagoon

ATCC BAA-1022

9

A. lanthieri

Pig manure

LMG 28516

10

A. marinus

Mix seawater, starfish and seaweed

LMG 25770

11

A. molluscorum

Mussels and oysters

LMG 25693

12

A. mytili

Mussels

LMG 24559

13

A. nitrofigilis

Roots

ATCC 33309

14

A. skirrowii

Lamb feces

ATCC 51322

15

A. thereius

Organs of aborted porcine

LMG 24486

16

A. trophiarum

Feces of fattening pigs

LMG 25534

17

A. venerupis

Shellfish

LMG 26156

18

Aeromonas allosaccharophila 

Diseased elvers

ATCC 51208

19

A. bestiarum

Infected fish

ATCC 51108

20

A. caviae

Epizootic of young guinea pigs

ATCC 15468

21

A. hydrophila

Ditch water

ATCC 13444

22

A. jandaei

Human feces

ATCC 49568

23

A. media

Marine fish

CDC 0435-84

24

A. popoffi

Drinking water production plant

BAA-243

25

A. salmonicida

Freshwater

CDC 0434-84

26

A. schubertii

Skin

ATCC 43700

27

A. sobria

Sludge

ATCC 35994

28

A. trota

Human feces

ATCC 49658

29

A. veronii

Red-leg frog

ATCC 9071

30

A. bv. veronii

Amputation Wound

ATCC 35625

31

Campylobacter jejuni

Human feces

ATCC 33291

32

C. coli

Swine

ATCC 43136

33

C. lari

Human feces

ATCC 43675

34

C. helveticus

Cat

ATCC 51210

35

C. fetus subsp. fetus

Blood

ATCC 15296

36

C. hyointestinalis

Intestine of swine

ATCC 35217

37

Escherichia coli O157:H7

Environmental isolate

-

38

E. coli

Canine

ATCC 35218

39

Pseudomonas shigelloides

Environmental isolate

-

40

Salmonella enterica subsp. arizonae

-

ATC C 13314

41

S. enterica subps. diarizonae

-

ATCC 12325

42

S. enterica subsp. houtenae

-

ATCC 29932

In addition, 29 A. faecis and ten A. lanthieri culture strains isolated from various environment including agricultural surface water and fecal sources were tested for assessment, validation and application of the three monoplex and eight multiplex PCR assays. Arcobacter cultures were recovered from human and animal fecal and agricultural water sources using a method previously described by Whiteduck-Léveillée et al. [13]. Briefly, the fecal samples were collected under aseptic conditions using sterile spatula and containers, and 1 g of fecal sample was ten-fold serially diluted by mixing in 9 mL of peptone water. The suspension (100 μL) was directly plated on Arcobacter Selective Isolation Agar (ASIA) (Oxoid, Nepean, ON) containing antimicrobial (fluorouracil, amphotericin-B, cefoperazone, novobiocin and trimethoprim) agents. However, the recovery of Arcobacter cultures from agricultural surface water samples, collected in sterile polypropylene bottles, was carried out by processing 500 mL of water through 0.22 μm sterile nitrocellulose filter using a vacuum-filtration system. The filters were placed on ASIA plate and incubated at 30°C under microaerophilic condition (85% N2, 10% CO2 and 5% O2) for 3 to 6 days. The presumptive Arcobacter culture isolates were, initially, selected based on conventional cultural characteristics (growth pattern and colony morphology) and Gram staining reactions. Further confirmation was carried out by Arcobacter genus- and species- specific PCR assays [41, 42].

Tetracycline susceptibility test

For pheno- and genotypic analysis, susceptibility of A. faecis and A. lanthieri strains to tetracycline was tested on Mueller-Hinton agar (Oxoid) using the agar dilution method according to CLSI [43]. The plates were incubated for 3 days in a microaerophilic condition at 30°C. Results were interpreted in accordance with the CSLI guidelines [44].

Nucleic acid extraction

For assay development, optimization and validation, the nucleic acid was extracted from reference strains and Arcobacter culture isolates recovered from surface water and fecal samples according to previously described boiling method [45]. Briefly, a single purified colony was suspended and gently mixed in a 100 μL 1xTE (pH 8.0) buffer. The cells were boiled (10 min.) and centrifuged (1 min.) at high speed. The purity and concentration of extracted DNA was determined by NanoDrop (ND-1000) spectrophotometer and agarose gel electrophoresis.

Gene-specific primers design, development and optimization of mono- and multiplex PCR assays for A. faecis

Based on a comprehensive whole-genome sequence analysis of A. faecis LMG 28519 reference strain, six virulence (cadF, ciaB irgA, mviN, pldA and tylA), two antibiotic resistance [tet(O) and tet(W)] and two cytolethal distending toxin (cdtA and cdtC) genes were identified. After alignments of these VAT gene sequences with other Arcobacter reference species sequences available in the GenBank database, a total of ten sets of VAT gene-specific oligonucleotide primer pairs for A. faecis, ranging from 20 to 28-mers, were designed. The ten pairs of primers, with their predicted fragment sizes, were used in one monoplex and four mPCR protocols as listed in Table 2. In order to check the specificity of the designed primers, initially, monoplex PCR assays were performed using only the forward and the reverse primer for detection of individual target gene. The PCR amplification reaction for each individual assay was carried out in the Mastercycler Gradient PCR system (Eppendorf, Hauppauge, NY), with a 25 μL reaction mixture containing 10-50 ng of A. faecis LMG 28519 DNA template, 1 U of Ex-Taq DNA polymerase and the compatible PCR reagents, including 1× buffer with MgCl2, 200 μM each of the dNTPs (Fisher Scientific, Nepean, ON), 0.1 μM of each set of the forward and reverse primer pair by adjusting volume to 25 μl with sterile distilled water in each monoplex PCR assay. The PCR reactions were conducted with an initial template denaturation (94°C for 3 min) followed by 35 cycles of amplification (denaturation at 94°C for 30 s, annealing ranging from 54 to 59°C for 30 s and extension at 72°C for 30 s) ending with a 5 min extension at 72°C for individual target genes. For all PCR reactions, A. faecis LMG 28519 as positive and A. butzleri ATCC 49616, A. cibarius LMG 21996 and A. lanthieri LMG 28516 reference strains as negative controls were used. The specificity of all ten primer sets was further evaluated individually using 13 Arcobacter spp. and 25 other bacterial reference species and strains (Table 1).
Table 2

List of oligonucleotide primer pairs and PCR protocols designed and optimized for the detection of VAT genes in A. faecis

Target VAT Gene

Oligonucleotide Primer Sequences (5’-3’)

Amplicon Size (bp)

Primer Concentration (μM)

Annealing Temperature (°C)

Assay 1

mviN

mviN F: TTC TTT GCA GCA ACA TTG GG

180

0.4

57

mviN R: TGC TAC CAT AGG AAA TAG GGC

0.4

irgA

irgA F: CTG GAC AGT ATG AAG GAA ACC C

105

0.4

irgA R: TTG CTT GAG TCC ATA ACA ACC A

0.4

Assay 2

cadF

cadF F: ATG GTG CAT TCG GAA ACT ACG G

192

0.1

60

cadF R: TTG GAG CTG GAG CAG GAA CTA

0.1

tylA

tylA F: TAG AAA CAA AGC AAG TGA ACT C

116

0.2

tylA R: CCT CTT CAA GTA GCT CTA TAT T

0.2

Assay 3

cdtA

cdtA F: TGT AGC CGA TGA ACT TAG TGA AGT AGA G

274

0.4

59

cdtA R: CCC AAC TGT TGC TTG TCC CAT TA

0.4

ciaB

ciaB F: AAG CAG TTG CCC TAG AGT GG

196

0.4

ciaB R: AGT GCT GGT CGT CCA ACA TAA

0.4

pldA

pldA F: GTG CTG CTG AAT TTA ACT GG

145

0.4

pldA R: GCA ACA CCT ATT CCT ACA TTT G

0.4

Assay 4

cdtC

cdtC F: AAG CAG AGG GTG AAA TAG CC

210

0.8

56

cdtC R: GAT TAG CAA ACT GTC CAC CAA ATA C

0.8

tet(W)

tet(W) F: ACA TCA TTG ATA CTC CAG GTC ACG

120

0.2

tet(W) R: TTT CAC TTT GTG GTT GAA CCC CTC

0.2

Assay 5

tet(O)

tetO F: GGA GGG GTT CAA CCA C AA AG

88

0.1

54

tetO R: CTA TGT AAA TAA AAT GGA TAG

0.1

In order to detect VAT genes in a more rapid and robust manner, four mPCR assays were optimized by combining and standardizing PCR protocols using two or three VAT gene-specific oligonucleotide primers. Each assay was designed such that the combination of the two or three primer pairs distinctively differed by a minimum of 50 bp in size in order to distinctively resolve PCR fragments on an agarose gel electrophoresis (Table 2). Based on the monoplex PCR results, mPCR assays were further optimized where various parameters particularly concentrations of primers (0.1 to 1.0 μM), Ex-Taq DNA polymerase (0.6 to 2 U), dNTPs (100 to 200 μM each of the four dNTPs), buffer strength (1.0× to 2.0×) and concentration (0.1-0.5 μM) were tested. The simultaneous gene amplifications were performed in a reaction volume of 25 μl consisting of variable (1 to 100 ng μL-1) DNA concentrations. Four PCR tubes containing two or three sets of primer pairs for the simultaneous detection of nine target VAT genes were processed with an initial denaturation at 94°C for 2 min followed by 35 cycles (except 30 cycles for cadF and tylA genes) of amplification including denaturation at 94°C for 30 s, different annealing temperatures (ranging from 54 to 60°C) for each mPCR assay (Table 2) and extension at 72°C for 30 s ended with a 5 min final extension at 72°C.

The expected amplicon sizes were small; therefore, each mono- and multiplex PCR reaction was electrophoresed on a 2.5% agarose gel matrix (Fisher Scientific). A 100 bp DNA size marker (Life Technologies, Grand Island, NY) was used to confirm the expected amplicon sizes of each target gene. The agarose gels were stained (ethidium bromide 0.5μg mL-1), scanned and photographed using an Alpha Imager (Fisher Scientific) gel documentation system.

Gene-specific primers design and optimization of mono- and multiplex PCR assays for A. lanthieri

For A. lanthieri, a total of 11 including six virulence (cadF, ciaB, irgA, mviN, pldA, and tylA), two antibiotic resistance [tet(O) and tet(W)] and three cytolethal distending toxin (cdtA, cdtB, and cdtC) genes were identified based on genome sequence analysis of A. lanthieri LMG 28516 reference strain. Each gene sequence was further aligned with the sequences of other Arcobacter reference species available in the GenBank database. For mono- and multiplex PCR assays, 11 A. lanthieri gene-specific oligonucleotide primer sets (ranging from 20 to 24-mers) were designed from variable regions of each gene with a minimum of 50 bp for easy differentiation of amplicons on an agarose gel electrophoresis analysis (Table 3). The specificity of each assay was individually performed as monoplex PCR using A. lanthieri LMG 28516 reference strain, several Arcobacter spp. and other bacterial species and strains as positive and negative controls, respectively.
Table 3

List of oligonucleotide primer pairs and protocols designed for the detection of VAT genes in A. lanthieri strains

Target VAT Gene

Oligonucleotide Primer Sequences (5’-3’)

Amplicon size (bp)

Primer Concentration (μM)

Annealing Temperature (°C)

Assay 1

cdtB

cdtB F: GCA AAA GGT GAT TGG GCT CC

303

0.4

56

cdtB R: TCC TCC AGC TCC TTG AAC AC

0.4

cadF

cadF F: TCC AAC TCC AGT TGC TGC TC

243

0.4

cadF R: TGT CCT TCG ATG TCA GCT TTC

0.4

irgA

irgA F: AGA GCT GTT GGT TGG GAT GG

186

0.4

irgA R: TGC ATT TGC TCT TGT AGG GT

0.4

Assay 2

cdtC

cdtC F: GAT GAA TCC ACC AGA AAT AGA G

196

0.3

57

cdtC R: TTT GGG ATC AAG AGT ATA AAG TTC

0.3

pldA

pldA F: TGC TCC ATT TAG AGA AAC TAA C

132

0.1

pldA R: GAA CGA GAT TCT TCA CCA TCT T

0.1

Assay 3

cdtA

cdtA F: CAG GAA TAG ATC TCG CTA CAA ATG

220

0.3

55

cdtA R: TTT GGT AGA AGA GGA AGT TCA TTG

0.3

mviN

mviN F: ACC TTT GGT TCT TCA ACT TTA C

170

0.4

mviN R: CGT GCT ACC ATA GGA AAT AGG

0.4

Assay 4

ciaB

ciaB F: GAT AGA TGC TAT TCT GCT CTT G

207

0.2

60

ciaB R: ATC TTC ACT AAA TGC TAC TAT T

0.2

tylA

tylA F: GAC ATT GTA ACA TGT GAT GTA TCT T

125

0.1

tylA R: TTT ACA TTT GTT CCC ACT TCA AA

0.1

Assay 5

tet(O)

tetO F: TCA TAC ACT TAT ACA CTT GAT GC

94

0.2

62

tetO R: CTC TAT ATT CAT TTG CAA CAT CAA CT

0.2

Assay 6

tet(W)

tetW F: AAT CAT ACA CTT ATA CAC TTG ATG CAC

197

0.1

60

tetW R: TTT AAT TCC TTC AAC TAT CTC TTC TTC

0.1

Based on gene-specific amplification results of each developed monoplex PCR assay, four mPCR assays were further optimized using a combination of two or three sets of primer pairs of six virulence and three toxin genes. As mentioned in the preceding section, several parameters were investigated to optimize mPCR protocols including primer concentrations (0.1 to 1.0 μM), Ex-Taq DNA polymerase (0.5 to 2 U), dNTPs (100 to 200 μM each of the four dNTPs) and buffer strength (1.0× to 2.0×) along with Bovine Serum Albumin (BSA) concentration (0.1 to 0.3 μM) were tested in order to obtain equal intensity of the amplified mPCR products. The mPCR assays were performed in 25 μL reactions with a minimum DNA concentration of 10 ng μL-1. Each mPCR assay, which incorporates the detection of either two or three virulence and/or toxin genes, consisted of a 35-cycle PCR program with an initial denaturation cycle of 94°C for 2 min, intermediate intra-cycle steps of 30 s each for denaturation at 94°C along with annealing where temperatures (ranging from 55 to 62°C) varied from assay to assay (Table 3) and extension at 72°C ended with a final elongation step of 5 min at 72°C.

Each mono- and multiplex PCR product was analyzed on an agarose gel electrophoresis, visualized on an ultraviolet transilluminator and photographed as described above.

Sensitivity and specificity assessment of mono- and multiplex PCR assays

The sensitivity of eleven optimized mono- and multiplex PCR assays was evaluated with representation of each target VAT gene specific for A. faecis and A. lanthieri. The purified DNA of each target species reference strain was quantified spectrophotometrically at 260 nm optical density, and ten-fold serially diluted (ranging from 100 ng μL-1 to 10 pg μL-1) corresponding to 105 to 101 CFU mL- 1 were prepared in sterile water. The detection limits were determined for each target species and gene by the mono- and multiplex PCR assays. In order to avoid any cross-reaction of our species- and gene-specific primers with Arcobacter species, other than A. faecis and A. lanthieri, and 40 other bacterial reference species and strains along with negative controls (PCR master mix without DNA template and water) were also included in each assay.

Evaluation and validation of specificity of developed assays

In order to evaluate the performance in terms of reproducibility and validity of the designed primers and PCR conditions for a total of three mono- and eight multiplex PCR assays, 29 A. faecis and ten A. lanthieri strains from various human and animal fecal sources and agricultural surface water samples were used for this study. The isolates were previously tested using standard conventional microbiology procedures and further confirmed by genus- and species-specific PCR assays as described above. Furthermore, the specificity of amplified products of 21 target VAT genes were evaluated by sequencing PCR amplicons of two of each target species isolated from fecal and water samples along with reference strains were purified using a QIAquick gel extraction kit (Qiagen, USA). The purified PCR products were sequenced using an ABI 3130xL Genetic Analyzer (Applied Biosystems) according to the manufacturer’s recommendations. The data was analyzed against the global database using a BLAST search engine for species- and gene-level confirmation of positive isolates.

RNA extraction and cdt gene expression analysis

In order to examine the transcriptional expression of the cdt (cdtA, cdtB and cdtC) genes among A. faecis and A. lanthieri isolates, total RNA was extracted by using NucleoSpin RNA kit (Macherey Nagel, D-Mark Bioscience, Germany) according to the manufacturer’s instructions. RNA was suspended in an appropriate amount of RNase-free water and RNA concentrations estimated by Qubit 3.0 fluorometer (Thermo Fisher Scientific, Waltham, MA, USA). Reverse transcriptase PCR (RT-PCR) was carried out using iScript gDNA Clear cDNA synthesis kit (BioRad, USA) according to the manufacturer’s instructions. RT-PCR primers listed in Tables 2 and 3 were used to amplify cdtA, cdtB and cdtC genes. PCR reactions were performed on the cDNA template after the addition of Taq DNA polymerase, deoxynucleoside triphosphates, 1× buffer with MgCl2 and each set of cdt gene primers with the incubation conditions of 95°C for 2 min followed by 35 cycles at 95°C for 30 s, 56 to 59°C for 30 s and 72°C for 30 s with a final incubation at 72°C for 5 min. PCR products were run on a 2% agarose gel and visualized.

Results

Specificity and optimization of species- and gene-specific primers and protocols in monoplex PCR assays

Initially, the specificity of 21 VAT gene primers and optimization of PCR protocols for A. faecis and A. lanthieri were tested with their corresponding reference DNA by monoplex PCR (Tables 2 and 3), and confirmed the expected amplicon sizes by agarose gel electrophoresis (data not shown). In this optimization step, all ten and 11 VAT genes investigated were detected in the A. faecis and A. lanthieri reference strains, respectively. The A. faecis primers specifically amplified with expected amplicon sizes for six virulence [cadF (192 bp), ciaB (196 bp), irgA (105 bp), mviN (180 bp), pldA (145 bp) and tylA (116 bp)], two  cdt [cdtA (274 bp) and cdtC (210 bp)] and two antibiotic resistance [tet(O) (88 bp) and tet(W) (120bp)] genes, respectively. Similarly, for A. lanthieri reference strain, specific PCR products were obtained with expected sizes for six virulence [cadF (243 bp), ciaB (207 bp), irgA (186 bp), mviN (170 bp), pldA (132 bp) and tylA (125 bp)], three cytolethal distending toxin [cdtA (220 bp), cdtB (303), and cdtC (196 bp)] and two antibiotic resistance [tet(O) and tet(W)] genes with typical amplicon sizes of 94 and 197 bp, respectively. The specificity of the developed primers and monoplex PCR protocols for each target species and VAT genes was also tested on 15 Arcobacter and other bacterial reference strain DNA templates (Table 1). The results showed that all assays had specificities only for A. faecis and A. lanthieri reference strains tested.

Development and optimization of mPCR assays

Furthermore, a total of eight single-tube mPCR assays were developed and optimized for the detection of nine VAT genes in A. faecis and A. lanthieri reference strains, respectively. However, PCR assays for three antibiotic resitance genes including tet(O) for A. faecis andtet(O) and tet(W) for A. lanthieri were remain used as monoplex due to the limitation in amplicon sizes and cross-amplification reaction with other genes investigated. To optimize the amplification of all primer pairs in the mPCR assays, initially the optimum annealing temperature for the mPCR reaction was determined. Temperature gradient PCR reactions determined that the appropriate annealing temperature ranged from 54 to 62°C for the mPCR assays. To further optimize each mPCR assay, the manipulation of primer concentration showed effective results. In each monoplex PCR assays, 0.4 μM primer concentration was used; however; to improve differences in the levels and intensity of amplification between different amplicons, the concentration of the primer pairs that amplified more efficiently were optimized using 0.1 to 0.4 μM concentration, while conversely, the concentration of the primer pair that amplified less efficiently were increased to 0.8 μM (Tables 2 and 3). BSA significantly enhanced PCR amplification yield when used at 0.3 μM. In each case, the PCR assays showed no primer-dimer interference or non-specific bands and produced the expected amplicon fragment sizes as obtained in monoplex PCR assays for A. faecis including 180 and 105 bp for mviN and irgA genes (Assay 1); 192 and 116 bp for cadF and tylA genes (Assay 2); 274, 196 and 145 bp for cdtA, ciaB and pldA genes (Assay 3); 210 and 120 bp for cdtC and tet(W) genes (Assay 4); whereas 88 bp for tet(O) gene (Assay 5) (Table 2; Fig. 1a, b, and c). On the other hand, each optimized mPCR assay, for A. lanthieri, produced same amplicons obtained during optimization of monoplex PCR assays with expected amplicon sizes of 303, 243 and 186 bp for cdtB, cadF and irgA genes (Assay 1); 196 and 132 bp for cdtC and pldA genes (Assay 2); 220 and 170 bp for cdtA and mviN genes (Assay 3); 207 and 125 bp for ciaB and tylA (Assay 4), whereas 94 bp for tet(O) (Assay 5) and 197 bp for tet(W) (Assay 6) (Table 2; Fig. 2a, b and c). Each mPCR assay was further evaluated for the specificity of the protocol by using control reference strains of Arcobacter spp. The mono- and multiplex PCR products were specifically obtained for each target gene of reference or field strain DNA, which indicates an absence of interference and non-specificity between any of the VAT gene primers or among amplified products.
Fig. 1

Typical amplicons for gene-specific mPCR assay developed for the detection of VAT genes in A. faecis. Panel a Lane 1: mviN (180 bp) and irgA (105 bp); and Lane 5: cadF (192 bp) and tylA (116 bp) genes; Panel b Lane 1: cdtA (274 bp), ciaB (196 bp) and pldA (145 bp); and Lane 5: cdtC (210 bp) and tet(W) (120 bp) and; Panel c Lane 1: tet(O) (88 bp) gene. Lanes 1: A. faecis LMG 28519 served as control positive; Lanes 2-4 and 6-8: A. butzleri ATCC 49616, A. cibarius LMG 21996, A. lanthieri LMG 28516 and Lanes 5 (Panel c), 9&10 (Panels a and b) served as control negative. Lane M: 1kb DNA marker

Fig. 2

Typical amplicons for each gene-specific mono and multiplex PCR assays developed for the detection of virulence, antibiotic resistance and toxin genes in A. lanthieri. Panel a Lane 1: cdtB (303 bp), cadF (243 bp) and irgA (186 bp); Lane 5: cdtC (196 bp) and pldA (132 bp); Panel b Lane 1: cdtA (220 bp) and mviN (170 bp); Lane 5: ciaB (207 bp) and tylA (125 bp); Panel c Lane 1: tet(O) (94 bp); Lane 5: tet(W) (197 bp); Lanes 1&5: A. lanthieri LMG 28516 served as control positive; Lanes 2-4 and 6-8: A. butzleri ATCC 49616, A. cibarius LMG 21996 A. faecis LMG 28519 and Lanes 9&10 served as control negative. Lane M: 1kb DNA marker

Evaluation of developed PCR assays and prevalence of VAT genes

In order to validate the developed mono- and multiplex PCR assays, and determine the degree of pathogenicity of the A. faecis and A. lanthieri by investigating the prevalence of VAT genes in field isolates, a total of 29 A. faecis cultures isolated from human and animal fecal and agricultural water samples were tested (Fig. 3). Interestingly, of the total ten VAT genes tested, all strains showed positive amplification for all genes at a high frequency ranging from 93 to 100% (Table 4) where cadF, irgA, tylA, cdtC and tet(W) genes were detected in all strains. However, of the total ten A. lanthieri strains (Figs. 4 and 5), only one strain showed negative amplification reaction for all VAT genes. However, one strain showed negative amplification for irgA, tylA, tet(O), cdtA and cdtC genes (Table 4). Similarly, based on the CLSI tetracycline breakpoints, all except one isolate of each species showed resistance to tetracycline which correlates with the tet(O) and tet(W) gene and species-specific PCR results. In addition, of the total 29 A. faecis and 10 A. lanthieri isolates, results of the RT-PCR analyzing the expression of cdt encoding gene showed detection of cdtA (70%; n= 20) and cdtC (87%, n= 25) genes in A. faecis compared to A. lanthieri isolates where expression of cdtA, cdtB and cdtC genes was detected at a variable rate ranging from 60 to 70%.
Fig. 3

Evaluation and validation of five species-specific mono- and multiplex PCR assays developed for the detection of VAT genes in A. faecis field isolates. Panels a and b Lanes 2-3: irgA and mviN genes; Lanes: 5-6 cadF and tylA genes; Lanes: 8-9 cdtA, ciaB and pldA; Lanes 11-12: cdtA and tet(W) genes; and Lanes 15-16 tet(O) gene. Lanes 1, 4, 7, 10 and 14: Control positive A. faecis LMG 28519; Lane 13&17: Control negative; Lane M: 1kb and 300 bp DNA Markers

Table 4

Number (percent) of virulence, antibiotic resistance and toxin (VAT) genes detected in A. faecis and A. lanthieri strains isolated from agricultural surface water and  various fecal sources

Species

No. of Isolates

Virulence genes

Antibiotic resistance genes

Toxin genes

cadF

ciaB

irgA

mviN

pldA

tylA

tet(O)

tet(W)

cdtA

cdtB

cdtC

A. faecis

29

29 (100)

28 (97)

29 (100)

27 (93)

28 (97)

29 (100)

27 (93)

29 (100)

28 (97)

NDa

29 (100)

A. lanthieri

10

9 (90)

9 (90)

8 (80)

9 (90)

9 (90)

8 (80)

8 (80)

9 (90)

8 (80)

9 (90)

8 (80)

aGene not detected

Fig. 4

Evaluation and validation of four species-specific mPCR assays developed for the detection of VAT genes in A. lanthieri field isolates (Lanes 2-3: cdtB, cadF, and irgA genes; Lanes 5-6: cdtC and pldA genes; Lanes 8-9: cdtA and mviN genes; Lanes 11-12: ciaB and tylA genes). Lanes 1, 4, 7 and 10: A. lanthieri LMG 28516 control positive; Lane 13: Control negative; Lane M: 1kb DNA Marker

Fig. 5

Evaluation and validation of PCR amplicons from each assay developed for the detection of tet(O) (Lanes 1-3) and tet(W) (Lanes 4-6) genes in A. lanthieri field isolates: Lanes 1 and 4: Control positive A. lanthieri LMG 28516; Lanes 2-3 and 5-6: field isolates; Lane 7: Control negative; Lane M: 1kb DNA Marker

The specificity of each targeted gene-specific primer pair of A. faecis and A. lanthieri was confirmed by sequencing of positive amplicons of reference strains and selected field isolates (Additional file 1: Table S1). The sequences were confirmed by available sequence data analysis where ≥99% sequence homology was observed to the corresponding target species-specific VAT gene.

Sensitivity of the developed PCR assays

Furthermore, the detection sensitivity of each mono- and multiplex PCR assay developed for a total of 21 genes of two target species was determined and confirmed by examining serially diluted (ten-fold) DNA templates (ranging from 100 ng μL-1 to 10 pg μL-1) of each target gene primer mixtures. Each targeted gene was amplified with a DNA concentration as low as 10 pg μL-1 by observing distinctive multiple PCR products with expected amplicon sizes on a 2.5% agarose gel which suggests that a minimum of 10 pg μL-1 of genomic DNA can detect target VAT gene in one of the target species by using this method.

Discussion

Although Arcobacter spp. have been considered as emerging human pathogens, the pathogenicity, toxin production and virulence mechanism still need to be fully elucidated [32]. After the first A. butzleri genome sequence, several virulence-associated genes were revealed that showed similarities with other bacteria such as Campylobacter, E. coli and Vibrio spp. [19], while a number of studies reported the prevalence of these genes in Arcobacter spp. [6, 10, 14]. These study findings established a cornerstone in identifying Arcobacter as an important pathogen that has potential to cause health risk to humans and animals. Of the other available detection techniques, these studies applied PCR assay that has an ability to detect the pathogens and target genes more rapidly and accurately compared to culturing, microscopy, and antigen based tests that have limited detection capacity especially when it comes to detection of a specific gene or pathogenic organism to the species-level. However, mPCR assay can be performed from a single or set of DNA templates rather than analyzing several DNA aliquots for an individual species or gene where the results can be obtained in more efficient and cost effective manner by reducing the possibility of cross-contamination. The major advantage of combining multiple primer pairs together in a single-tube PCR assay reduces the overall quantity of materials used per assay, the amount of time required for high throughput screening, thereby reducing the cost of performing these assays in more robust and rapid manner. However, the major challenges in developing an mPCR assay are primer design, primer concentration, PCR protocol (e.g., annealing and extension time and cycles) and avoiding primer-dimer formation for obtaining an optimal amplification of multiple products for all target species or genes [46]. Formation of primer dimer occurs prior to the first PCR cycle and is typically caused by primers that have complementary overlaps. By choosing a variable terminal sequence at 3’ ends of multiple primers, the formation of stable overlaps can successfully be avoided [47].

With the rapidly evolving technology, genome sequence analysis is becoming common to identify and confirm specific genes for assessing the pathogenicity of a microorganism because of the improved BLAST program and continuous update of genome data. This approach is more convenient and effective e.g., virulence and antibiotic resistance-specific genes were identified in A. butzleri and A. cryaerophilus by comparative genomics [19, 48]. Researchers have developed mPCR assays for rapid identification of Arcobacter spp. [45, 49] as well as analysis of the virulence-associated genes of Arcobacter spp. [16]. The Arcobacter genus-specific virulence-associated gene-based mono- and multiplex PCR assays have developed and are considered a better target for assessing the pathogenicity of Arcobacter spp. isolated from various sources [10, 11, 16, 50]. However, these PCR assays were less accurate and failed to amplify all targeted virulence-associated genes in other Arcobacter spp. except A. butzleri likely due to heterogeneity in the primer sequences of other Arcobacter spp. [16]. Moreover, the cdt (cdtA, cdtB and cdtC) genes that play role as a virulence factor in promoting diseases by toxin-producing pathogens and genes that enable antibiotic resistance were not investigated in these studies [19, 51]. A. faecis and A. lanthieri are closely related to pathogenic species of Arcobacter (e.g., A. butzleri and A. cryaerophilus) [4, 13]; however, there has been no species- and gene-specific screening method developed that can efficiently be used to determine the pathogenicity, antibiotic resistance and toxicity which are all important factors when assessing the level of health risk an organism causes to humans or animals.

To our knowledge, this study reports the first Arcobacter species- and gene-specific mono- and multiplex PCR methods that have been developed and validated to detect and analyze the prevalence of several VAT genes in A. faecis and A. lanthieri individually. Although the initial time investment required to optimize species- or gene-specific mPCR assay was significantly more than that of the optimization of a monoplex assay, the long-term benefits are greater than the short-term costs. The high throughput and rapid screening of field isolates of both species for the analyses of the VAT genes cannot be understated. The process of optimizing species- and gene-specific mPCR assays commenced with careful design of primer pairs that may not only amplify sequences specific to the target gene, but also do not interfere with the other primer pairs used in each assay. Moreover, the fragment size can distinguishably be observed on an agarose gel. In the first phase of the study, all primers were carefully designed coupled with Ex-Taq DNA polymerase and BSA to improve yield and intensity of amplified products in a mixture of variable concentration of primers and DNA. To avoid preferential amplification of the shorter amplicons, we optimized multiple factors such as the concentration of each primer and the extension time of PCR cycles that may affect an mPCR assay. Although the primer pairs designed by considering various parameters using primer design software, they do not show optimized results until manipulation of several parameters (ranging from primers, Taq DNA polymerase, buffer and DNA concentrations to addition of BSA at various concentrations, annealing temperature and time in the PCR protocols) were applied during optimization of each mPCR assay. Moreover, multiple primer pairs with small amplicon sizes and distinctive differentiation preferably with a minimum amplicon length difference of 50 bp between amplicons of multiple target genes were designed for an mPCR assay with the aim to apply these assays in a real-time PCR environment which made optimization of each single-tube mPCR assay more challenging. After optimization of the above mentioned parameters, specific and consistent amplification of all targeted VAT genes in the mono- and multiplex PCR combinations were successfully achieved where a total of 11 including three mono- and eight multiplex PCR-based assays were developed, optimized and validated for the identification and differentiation of six virulence (irgA, mviN, cadF, tylA, ciaB and pldA), two antibiotic resistance [tet(O) and tet(W)] and two/ three cytolethal distending toxin (cdtA, cdtB and cdtC) genes in A. faecis and A. lanthieri, respectively. In the first step, the primer set for each gene was individually optimized and tested in A. faecis and A. lanthieri reference strains where positive amplification reactions of all targeted VAT genes with expected product sizes were observed. Based on the monoplex PCR assay results, eight mPCR assays were further developed using a combination of two or three VAT gene primer pairs. Each optimized mPCR assay gave results consistent and similar, in terms of size and intensity, to the monoplex PCR assay and effectively detected VAT genes by distinguishably producing 18 clear bands in eight mPCR assays on an agarose gel electrophoresis. Due to limitations in fragment size and cross-reaction with primer pairs of other VAT genes, tet(O) and tet(W) gene were used as monoplex PCR assays.

To demonstrate the future utility and asses the degree of pathogenicity, the developed mono- and multiplex PCR assays were further validated by testing A. faecis and A. lanthieri strains isolated from agricultural surface water and fecal samples. Of the total ten VAT genes, cadF, irgA, tylA, tet(W) and cdtC genes were detected in all A. faecis field isolates compared to one isolate that did not show amplification to ciaB, pldA, and cdtA genes; whereas, two isolates were negative for mviN and tet(O) genes. On the other hand, one strain of A. lanthieri showed negative amplification for all 11 VAT genes compared to two strains that did not amplify irgA, tylA, tet(O), cdtA and cdtC genes when field isolates were tested for evaluation and validation of developed assays. The results are in agreement with other studies where cadF, ciaB, mviN, pldA, and tylA virulence genes were detected at a high frequency in A. butzleri and A. skirrowii strains suggesting that these genes are common within the genus Arcobacter [10, 11, 14, 15, 16, 32, 52]. A high prevalence of ciaB gene suggests that A. faecis and A. lanthieri are able to easily internalize into epithelial cells in the gastrointestinal lining that contributes in mediating enteritis [18]. On the other hand, irgA gene was detected in A. faecis and A. lanthieri strains tested which is not in concordance with previous studies where irgA gene was detected at a low frequency in Arcobacter spp. [10, 11]. The key function of irgA in vivo is uptake of iron, which is an essential but often severely limited nutrient in animal hosts meaning that low iron concentrations are less likely to prevent the pathogen from infecting and colonizing the host. This gene plays a key role in causing urinary tract infection by uropathogenic E. coli [53, 54]. However, the prevalence of irgA was significantly higher than the frequency observed in the aforementioned studies. This could be due to geographical differences from where the sample was obtained, for instance the samples analyzed in this study were isolated in Canada while these studies contained strains isolated from other parts of the world. Interestingly, similar to A. faecis, tet(O) and tet(W) antibiotic resistance genes were also detected at a significantly high frequency in A. lanthieri. The results are also supported by the previous study [31, 48] where tetracycline resistance in A. cryaerophilus was observed, suggesting that tetracycline resistance is more frequent in the genus Arcobacter than reported. Other than Arcobacter and Campylobacter spp., tet(O) and tet(W) genes were detected more significantly than other tet-genes [e.g., tet(B) and tet(C)] in commensal bacteria isolated from fecal and water samples [55]. Interestingly, similar to our optimized PCR assays where ≥93 A. faecis and ≥80% A. lanthieri isolates showed positive amplification for tet(O) and tet(W) genes, the phenotypic resistance to tetracycline was also observed at a significantly high (97%) rate in both species. These results suggest that when these species are clinically identified for tetracycline resistance, genotypic screening should be performed for the presence of tet genes since rapid, simple and reliable methods for antibiotic susceptibility are important for appropriate therapy. Moreover, identification and determination of the antimicrobial susceptibility test that requires a minimum of 3-days compared to the developed PCR assays that can be done in a few hours, therefore, the developed PCR assays can be used for confirmation of the results obtained by conventional phenotypic methods when necessarily required.

In contrary to the previous studies [19, 22], which reported the distinct absence of cdt genes in arcobacters and in whole genome sequence of A. butzleri, cdtA and cdtC genes were identified in A. faecis genome sequence where PCR assays detected these genes at high frequency (cdtA 93% and cdtC 100%) in field isolates. Interestingly, cdtB gene was not identified in the genome sequence of the A. faecis reference strain. This leads to a future research on genome sequencing of one of the field isolates that might contain all three cdt genes. If that is not the case, given bacterial ability to rapidly acquire new genes, it remains important to note that the field isolates currently possess both cdt genes that were investigated in this study. In contrast to A. faecis, all three cdt (cdtA, cdtB, cdtC) genes were found in the  A. lanthieri genome sequence. The rates of detection of cdtA, cdtB and cdtC were significantly high where eight strains (80%) were shown positive for cdtA and cdtC genes compared to cdtB gene detected in nine strains (90%). The cdt genes were also detected at a variable frequency in Campylobacter spp. isolated from various sources [56, 57, 58]. The high frequency of prevalence of VAT genes and the results of the expression analysis of cdt genes where genes are functional in A. faecis and A. lanthieri strains indicate that these species of Arcobacter could potentially be pathogenic that can pose health risks to humans and animals.

One of the major advantages of these newly developed PCR assays is the significant specificity and sensitivity where each mono- or multiplex PCR assay showed specificity to their target species-specific genes at a least detection limit of 10 pg μL-1 DNA concentration (equivalent to 101 CFU mL-1). The infectious dose for each pathogen varies; however, according to US EPA [59] guidelines, a pathogen can cause a disease when ingested at the rate of ≥103 CFU mL-1. Although the infectious dose of A. faecis and A. lanthieri is not determined yet, the detection sensitivity of each assay is within the range that has been used for other bacterial pathogens and can be applied for developing standard for infectious dose and pathogenicity assessment of these species isolated from clinical and various environmental niches.

Conclusion

The significance of investigating and detecting several VAT genes in A. faecis and A. lanthieri reference and field strains by developing, optimizing and validating eleven mono- and multiplex PCR assays described in this study would add useful knowledge to apply in the field of molecular microbiology. Moreover, the sensitivity, reproducibility and speed of the eight mPCR assays are enhanced due to the optimal application of several PCR parameters and addition of BSA that further enhanced the specificity of the assays by testing several other Arcobacter and bacterial species and strains as control. Overall, the rapidness and number of VAT genes tested in the developed PCR assays suggest that these novel PCR-based cost effective methods can be applied for rapid and possibly high throughput screening and assessment of pathogenic A. faecis and A. lanthieri strains in diagnostic laboratories and etiological/ epidemiological studies. Based on these results, further research is warranted to assess the role of these virulence factors on human or animal health by gene expression analysis or analysing the adhesive, invasive and toxicity capabilities in cell cultures using clinical and environmental isolates under various environmental conditions.

Notes

Acknowledgements

We thank co-op students Linda Liu, Mary G. Miltenburg, Mark Libby, and other field crew for collecting samples and providing laboratory and technical assistance.

Funding

The funds for this research were provided by Agriculture and Agri-Food Canada under project J-001012. The funding source was not involved in study design, sample collection, data analysis and interpretation.

Availability of data and materials

The data generated and analyzed in this study are available upon request. In this paper, all additional data generated or analyzed in this research study is presented as Additional file 1: Table S1.

Authors’ contributions

MZ, ZA, and IK conceived study, performed genome sequence analyses and designed the experiments. MZ, MC and IK designed primers and PCR protocols, performed laboratory experiments, analyzed results and drafted the manuscript. ET, GT, GW, MS and DL coordinated in selecting field sampling sites and sample collection protocols as well as contributed in interpreting results data and editing manuscript. All authors reviewed, edited and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary material

12866_2018_1357_MOESM1_ESM.docx (27 kb)
Additional file 1: Table S1. Validation of VAT PCR assays by sequencing of PCR products for A. faecis and A. lanthieri reference and field strains isolated from fecal and water samples. (DOCX 27 kb)

References

  1. 1.
    Vandamme P, Falsen E, Rossau R, Hoste B, Segers P, Tytgat R, De Ley J. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov. Int J Syst Bacteriol. 1991;41(1):88–103.CrossRefGoogle Scholar
  2. 2.
    Diéguez AL, Balboa S, Magnesen T, Romalde JL. Arcobacter lekithochrous sp. nov., isolated from a molluscan hatchery. Int J Syst Evol Microbiol. 2017;67:1327–32.CrossRefGoogle Scholar
  3. 3.
    Vandamme P, Vancanneyt M, Pot B, Mels L, Hoste B, Dewettink D, Vlaes L, van den Borre C, Higgins R, Hommez J. Polyphasic taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov., and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary specimens. Int J Syst Evol Bacteriol. 1992;42:344–56.CrossRefGoogle Scholar
  4. 4.
    Whiteduck-Léveillée K, Whiteduck-Léveillée J, Cloutier M, Tambong JT, Xu R, Topp E, Arts MT, Chao J, Adam Z, Lévesque CA, Lapen DR, Villemur R, Talbot G, Khan IU. Identification, characterization and description of Arcobacter faecis sp. nov., isolated from human waste septic tank. Syst App Microbiol. 2016;39:93–9.CrossRefGoogle Scholar
  5. 5.
    Levican A, Alkeskas A, Günter C, Forsyth SJ, Figueras MJ. The adherence and invasion of human intestinal cells by Arcobacter species and their virulence genotype. Appl Environ Microbiol. 2013;79(16):4951–7.CrossRefGoogle Scholar
  6. 6.
    Levican A, Collado L, Figeuras MJ, Aguilar C, Yustes C, Diéguez AL, Romalde JL. Arcobacter bivalviorum sp. nov. and Arcobacter venerupis sp. nov. new species isolated from shellfish. Syst Appl Microbiol. 2012;35(3):133–8.CrossRefGoogle Scholar
  7. 7.
    Ho HT, Lipman LJ, Gaastra W. Arcobacter, what is known and unknown about a potential foodborne zoonotic agent! Vet Microbiol. 2006;115:1–13.CrossRefGoogle Scholar
  8. 8.
    D’Sa EM, Harrison MA. Effect of pH, NaCl content, and temperature on growth and survival of Arcobacter spp. J Food Prot. 2005;68:18–25.CrossRefGoogle Scholar
  9. 9.
    Bessede E, Delcamp A, Sifre E, Buissonniere A, Megraud F. New methods for detection of campylobacters in stool samples in comparison to culture. J Clin Microbiol. 2011;49:941–4.CrossRefGoogle Scholar
  10. 10.
    Douidah L, de Zutter L, Baré J, De Vos P, Vandamme P, Vandenberg O, Van den Abeele M, Houf K. Occurrence of putative virulence genes in Arcobacter species isolated from humans and animals. J Clin Microbiol. 2012;50(3):735–41.CrossRefGoogle Scholar
  11. 11.
    Karadas G, Sharbati S, Hänel I, Messelhäußer U, Glocker E, Alter T, Gölz G. Presence of virulence genes, adhesion and invasion of Arcobacter butzleri. J Appl Microbiol. 2013;115(2):583–90.CrossRefGoogle Scholar
  12. 12.
    Tan J, File T, Salata R, Tan M. Infectious diseases. Expert guide series. In: The American College of Physicians. Philadelphia: Versa Press; 2008. p. 95.Google Scholar
  13. 13.
    Whiteduck-Léveillée K, Whiteduck-Léveillée J, Cloutier M, Tambong JT, Xu R, Topp E, Arts MT, Chao J, Adam Z, Lévesque CA, Lapen DR, Villemur R, Talbot G, Khan IU. Arcobacter lanthieri sp. nov., isolated from pig and dairy cattle manure. Int J Syst Evol Microbiol. 2015;65:2709–16.CrossRefGoogle Scholar
  14. 14.
    Tabatabaei M, Shirzad AH, Shavegh H, Khoshbakht R. Occurrence of six virulence-associated genes in Arcobacter species isolated from various sources in Shiraz, Southern Iran. Microb Pathol. 2014;66:1–4.CrossRefGoogle Scholar
  15. 15.
    Girbau C, Guerra C, Martinez-Malaxetxebarria I, Alonso R, Fernandez-Astorga A. Prevalence of ten putative virulence genes in the emerging foodborne pathogen Arcobacter isolated from food products. Food Microbiol. 2015;52:146–9.CrossRefGoogle Scholar
  16. 16.
    Whiteduck-Léveillée J, Cloutier M, Topp E, Lapen DR, Talbot G, Villemur R, Khan IU. Development and evaluation of multiplex PCR assays for rapid detection of virulence-associated genes in Arcobacter species. J Microbiol Methods. 2016;121:59–65.CrossRefGoogle Scholar
  17. 17.
    Konkel ME, Garvis SG, Tipton SL, Anderson DE Jr, Cieplak W Jr. Identification and molecular cloning of a gene encoding a fibronectin-binding protein (CadF) from Campylobacter jejuni. Mol Microbiol. 1997;24:953–63.CrossRefGoogle Scholar
  18. 18.
    Konkel ME, Kim BJ, Rivera-Amill V, Garvis SG. Bacterial secreted proteins are required for the internalization of Campylobacter jejuni into cultured mammalian cells. Mol Microbiol. 1999;32(4):691–701.CrossRefGoogle Scholar
  19. 19.
    Miller WG, Parker CT, Rubenfield M, Mendz GL, Wösten MMSM, Ussery DW, Stolz JF, Binnewies TT, Hallin PF, Wang G, Malek JA, Rogosin A, Stanker LH, Mandrell RE. The complete genome sequence and analysis of the Epsilonproteobacterium Arcobacter butzleri. Plos One. 2007;2(12):e1358.CrossRefGoogle Scholar
  20. 20.
    Cao L, Volgina A, Huang CM, Korostoff J, DiRienzo JM. Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol. 2005;58:1303–21.CrossRefGoogle Scholar
  21. 21.
    Purdy D, Leach SA, Hodgson AE, Buswell CM, Henderson I, McAlpine K. Characterisation of cytolethal distending toxin (CDT) mutants of Campylobacter jejuni. J Med Microbiol. 2000;49:473–9.CrossRefGoogle Scholar
  22. 22.
    Johnson LG, Murano EA. Lack of a cytolethal distending toxin among Arcobacter isolated from various sources. J Food Prot. 2002;65(11):1789–95.CrossRefGoogle Scholar
  23. 23.
    Adam Z, Whiteduck-Léveillée K, Cloutier M, Chen W, Lewis CT, Lévesque CA, Topp E, Lapen DR, Tambong JT, Talbot G, Khan IUH. Draft genome sequences of two Arcobacter strains isolated from human feces. Genome Announc. 2014a;2(2):e00113–4.CrossRefGoogle Scholar
  24. 24.
    Adam Z, Whiteduck-Léveillée K, Cloutier M, Chen W, Lewis CT, Lévesque CA, Topp E, Lapen DR, Tambong JT, Talbot G, Khan IUH. Draft genome sequences of three Arcobacter strains of pig and dairy cattle manure origin. Genome Announc. 2014b;2(3):e00377–14.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Granados-Chinchilla F, Rodríguez C. Tetracyclines in food and feedingstuffs: From regulation to analytical methods, bacterial resistance, and environmental and health implications. J Anal Methods Chem. 2017;2017:1–24.CrossRefGoogle Scholar
  26. 26.
    Chattopadhyay MK. Use of antibiotics as feed additives: a burning question. Front Microbiol. 2014;5:334.CrossRefGoogle Scholar
  27. 27.
    Hao H, Cheng G, Iqbal Z, Xiaohui A, Hussain HI, Huang L, Dai M, Wang Y, Liu Z, Yuan Z. Benefits and risks of antimicrobial use in food-producing animals. Front Microbiol. 2014;5:1–11.CrossRefGoogle Scholar
  28. 28.
    Quesada SP, Paschoal JAR, Reyes FAG. Considerations on the aquaculture development and on the use of veterinary drugs: special issue for fluoroquinolones - a review. J Food Sci. 2013;78:1321–33.CrossRefGoogle Scholar
  29. 29.
    US FDA. 2017. #209 Guidance for Industry, The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals, http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM216936.pdf.
  30. 30.
    Van Boeckel TP, Brower C, Gilbert M, Grenfella BT, Levina SA, Robinsoni TP, Teillant A, Laxminarayan R. Global trends in antimicrobial use in food animals. PNAS. 2015;112:5649–54.CrossRefGoogle Scholar
  31. 31.
    Yesilmen S, Vural A, Erkan ME, Yildirim IH. Prevalence and antimicrobial susceptibility of Arcobacter species in cow milk, water buffalo milk and fresh village cheese. Int J Food Microbiol. 2014;188:11–4.CrossRefGoogle Scholar
  32. 32.
    Ferreira S, Queiroz JA, Oleastro M, Domingues FC. Insights in the pathogenesis and resistance of Arcobacter: A review. Crit Rev Microbiol. 2014;25:1–20.Google Scholar
  33. 33.
    Otth L, Wilson M, Cancino R, Fernández H. In vitro susceptibility of Arcobacter butzleri to six antimicrobial drugs. Arch Med Vet. 2004;36(2):207–10.CrossRefGoogle Scholar
  34. 34.
    Son I, Englen MD, Berrang ME, Fedorka-Cray PJ, Harrison MA. Antimicrobial resistance of Arcobacter and Campylobacter from broiler carcasses. Int J Antimicrob Agents. 2007;29:451–5.CrossRefGoogle Scholar
  35. 35.
    Connell SR, Tracz DM, Neirhaus KH, Taylor DE. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob Agent Chemo. 2003;47(12):3675–81.CrossRefGoogle Scholar
  36. 36.
    Schnappinger D, Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol. 1996;165:359–69.CrossRefGoogle Scholar
  37. 37.
    Roberts MC. Update on acquired tetracycline resistance genes. FEMS Microbiol Lett. 2005;45(2):195–203.CrossRefGoogle Scholar
  38. 38.
    Levy SB, McMurry LM, Barbosa TM, Burdett V, Courvalin P, Hillen W, Roberts MC, Rood JI, Taylor DE. Nomenclature for new tetracycline resistance determinants. Antimicrob Agents Chemother. 1999;43:1523–4.CrossRefGoogle Scholar
  39. 39.
    Billington SJ, Songer JG, Jost B. Widespread distribution of a Tet W determinant among tetracycline-resistant isolates of the animal pathogen Arcanobacterium pyogenes. Antimicrob Agents Chemother. 2002;46:1281–7.CrossRefGoogle Scholar
  40. 40.
    Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232–60.CrossRefGoogle Scholar
  41. 41.
    Harmon KM, Wesley IV. Identification of Arcobacter isolates by PCR. Lett Appl Microbiol. 1996;23:241–4.CrossRefGoogle Scholar
  42. 42.
    Khan IUH, Cloutier M, Libby M, Lapen DR, Wilkes G, Topp E. Enhanced single-tube multiplex PCR assay for detection and identification of six Arcobacter species. J Appl Microbiol. 2017;123(6):1522–32.  https://doi.org/10.1111/jam.13597.CrossRefPubMedGoogle Scholar
  43. 43.
    Clinical and Laboratory Standards Institute (CLSI). Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated fastidious bacteria; Approved Guideline-Second Edition. CLSI document M45-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.Google Scholar
  44. 44.
    Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 21st informational supplement. CLSI M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute; 2011.Google Scholar
  45. 45.
    Khan IUH, Hill S, Nowak E, Edge TA. Effect of incubation temperature on the detection of thermophilic Campylobacter species from freshwater beaches, nearby wastewater effluents, and bird fecal droppings. Appl Environ Microbiol. 2013;79(24):7639–45.CrossRefGoogle Scholar
  46. 46.
    Henegariu O, Heerema NA, Diouhy SR, Vance GH, Vogt PH. Multiplex PCR: critical parameters and step-by-step protocol. BioTech. 1997;23:504–11.CrossRefGoogle Scholar
  47. 47.
    Dieffenbach CW, Lowe TM, Dveksler GS. General concepts for PCR primer design. Genome Res. 1993;3:S30–7.CrossRefGoogle Scholar
  48. 48.
    Millar JA, Raghavan R. Accumulation and expression of multiple antibiotic resistance genes in Arcobacter cryaerophilus that thrives in sewage. PeerJ. 2017;5:e3269.CrossRefGoogle Scholar
  49. 49.
    Houf K, Tutenel A, De Zutter L, Van Hoof J, Vandamme P. Development of a multiplex PCR assay for the simultaneous detection and identification of Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii. FEMS Microbiol Lett. 2000;193(1):89–94.CrossRefGoogle Scholar
  50. 50.
    Rathlavath S, Kohli V, Singh AS, Lekshmi M, Tripathi G, Kumar S, Nayak BB. Virulence genotypes and antimicrobial susceptibility patterns of Arcobacter butzleri isolated from seafood and its environment. Int J Food Microbiol. 2017;263:32–7.CrossRefGoogle Scholar
  51. 51.
    Pickett CL, Whitehouse CA. The cytolethal distending toxin family. Trends Microbiol. 1999;7(7):292–7.CrossRefGoogle Scholar
  52. 52.
    Lehmann J, Leroux C, Reimbold G, Charles M, Torres A, Morvan E, Baines Y, Ghibaudo G, Bano E. Novel sheet resistance measurement on AlGaN/GaN HEMT wafer adapted from four-point probe technique. Proceedings of the 2015 International Conference on Microelectronic Test Structures; 2015. p. 163–8.Google Scholar
  53. 53.
    Bauer RJ, Zhang L, Foxman B, Siitonen A, Jantunen ME, Saxen H, Marrs CF. Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection-usp, iha, and iroN (E. coli). J Infect Dis. 2002;185:1521–4.CrossRefGoogle Scholar
  54. 54.
    Tashima KT, Carrol PA, Rogers MB, Calderwood SB. Relative importance of three iron-regulated outer membrane proteins for in vivo growth of vibrio cholera. Infect Immun. 1996;64(5):1756–61.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Yang H, Byelashov OA, Geornaras I, Goodridge LD, Nightingale KK, Belk KE, Smith GC, Sofos JN. Presence of antibiotic-resistant commensal bacteria in samples from agricultural, city, and national park environments evaluated by standard culture and real-time PCR methods. Can J Microbiol. 2010;56:761–70.CrossRefGoogle Scholar
  56. 56.
    Krutkiewicz A, Klimuszko D. Genotyping and PCR detection of potential virulence genes in Campylobacter jejuni and Campylobacter coli isolates from different sources in Poland. Folia Microbiol. 2010;55(2):167–75.CrossRefGoogle Scholar
  57. 57.
    Laprade N, Cloutier M, Lapen DR, Topp E, Wilkes G, Villemur R, Khan IUH. Detection of virulence, antibiotic resistance and toxin (VAT) genes in Campylobacter species using newly developed multiplex PCR assays. J Microbiol Meth. 2016;124:41–7.CrossRefGoogle Scholar
  58. 58.
    Zheng J, Meng J, Zhao S, Singh R, Song W. Adherence to and invasion of human intestinal epithelial cells by Campylobacter jejuni and Campylobacter coli isolates from retail meat products. J Food Prot. 2006;69:768–74.CrossRefGoogle Scholar
  59. 59.
    US, EPA. Guidelines for water reuse United States Environmental Protection Agency, Washington DC. 1992.Google Scholar

Copyright information

© Crown. 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Matthew Zambri
    • 1
    • 2
  • Michel Cloutier
    • 1
  • Zaky Adam
    • 1
    • 3
  • David R. Lapen
    • 1
  • Graham Wilkes
    • 1
  • Mark Sunohara
    • 1
  • Edward Topp
    • 4
  • Guylaine Talbot
    • 5
  • Izhar U. H. Khan
    • 1
    Email author return OK on get
  1. 1.Ottawa Research and Development Centre (ORDC), Agriculture and Agri-Food CanadaOttawaCanada
  2. 2.Department of BiologyMcMaster UniversityHamiltonCanada
  3. 3.School of Information Technology and EngineeringUniversity of OttawaOttawaCanada
  4. 4.London Research and Development Centre (LRDC), Agriculture and Agri-Food CanadaLondonCanada
  5. 5.Sherbrooke Research and Development Centre (SRDC), Agriculture and Agri-Food Canada, SherbrookeQuebecCanada

Personalised recommendations